Acquired Bleeding Disorders

Abstract Number: PO0048

A Cardiac Amyloidosis Presentation: Atrial Mass Versus Thrombus

F. Alayoubi¹, G. Elgohary²

Abstract Number: PB0479

A comparison of thrombin generation ex vivo circuit and in critically ill patients requiring Extracorporeal Membrane Oxygenation

A. Doyle¹, K. Parmar², N. Gooby², K. Breen³, N. Barrett², A. Retter¹, B. Hunt¹

Abstract Number: PB0484

A comparison study of ROTEM® Sigma and ROTEM® Delta in a major tertiary hospital

N. Modica¹, L. Kaminskis¹, M. Anderson¹, S. P'ng², D. Pepperell²

Abstract Number: PB1001

A Novel Human Factor VIIa Chimera with Increased Tissue Factor-Independent Hemostatic and Anti-Inflammatory Activities

A. Fager¹, M. Hoffman², D. Monroe³

Abstract Number: PB0988

A TEG-guided treatment algorithm for major surgical bleeding

S. Dawson¹, A. Cain²

Abstract Number: PB0989

Acquired Factor V Inhibitor In a Patient With Metastatic Cancer

D. Dhami¹, P. Changizzadeh², C. Solowiej Singh³, S. Dhami⁴, S. Muttana⁵

Abstract Number: PB0990

Acquired FXI deficiency (aFXIdef) in a HIV + patient with SLE. Alternative evolution to lupus Anticoagulant (LA) during immunosuppressive therapy.

C. Seehaus¹, M. Lopez², L. Barrera³, P. Quiñones Maffassanti⁴, L. Ferreyra Garrott⁵, V. Privitera⁶, F. Chuliber⁷, D. Penchasky⁸, E. Viñuales⁸, J. Arbelbide⁸, M. Martinuzzo⁹

Abstract Number: PB0005

Acquired haemophilia presenting in a 14-year-old girl

J. Roganovic

Abstract Number: PB0475

Acquired von Willebrand Disease in a Patient Undergoing Extracorporeal Membrane Oxygenation

D. Cibele¹, C. Monteiro², S. Silva³, M. Lopes⁴, L. Gonçalves⁵, S. Teixeira⁶, I. Machado¹, M. Carvalho⁵, R. Roncon-Albuquerque⁷, C. Koch⁵

Abstract Number: VPB0003

Acquired von Willebrand syndrome in patients with monoclonal gammopathy: a single centre experience.

M. Costa-Pinto¹, M. Fernández², N. Rodríguez², A. Pérez-Rodríguez², M. Gómez-del-Castillo², T. Lado², M. Lopez-Fernandez³

Abstract Number: PB0474

Acquired von-Willebrand-disease in ECMO or LVAD patients: a comparative cohort study

T. Bajorat¹, J. Hildebrandt¹, B. Pannholzer², D. Kowalski¹, D. Juhl³, J. Kalbhenn⁴, A. Kowalski², B. Zieger⁵, A. Haneya², U. Nowak-Göttl¹

Abstract Number: PB0477

Age and sex distribution of the prevalence and incidence of hospitalisations and mortality due to bleeding in England 2014-2019

K. Creeper¹, A. Stafford², S. Choudhuri³, N. Tumian⁴, K. Breen⁵, A. Cohen⁶

Abstract Number: VPB0997

Analytical performance of different laboratory methods for measuring susoctog-alpha

C. Novembrino¹, I. Quaglia², M. Boscolo-Anzoletti³, E. Galbiati³, E. Dosio⁴, A. Valpreda⁴

Abstract Number: PB0481

Are levels of direct anticoagulant at the onset of hip fracture surgery associated with post-surgery bleeding?

A. Lubetsky¹, A. Levi², R. keshet³

Abstract Number: PB0991

Assessment of Interference by Emicizumab in the Measurement of Susoctocog Alfa Factor VIII Activity Using a Chromogenic Assay

L. Pan¹, A. Mokdad², P. Turecek³, M. Robinson⁴, N. Jain¹

Abstract Number: PB0485

Assessment of Trauma-Induced Coagulopathy Using a Microfluidic Model of Injury at Venous and Arterial Shear Regimes

S. Shea¹, R. Rassam¹, R. Fonseca², M. Canas², K. Thomas³, K. Bochicchio², G. Bochicchio², P. Spinella⁴

Abstract Number: PB0489

Audit of the use of Fibclot (Fibrinogen concentrate) in patients without congenital afibrinogenaemia

M. Ul-haq¹, G. Baidya², G. Gidley², E. Horn², A. Kanny², J. Tarrant³

Abstract Number: VPB0490

Audit on the use of fresh frozen plasma in a Tertiary Care Hospital

G. Ene¹, M. Raya Hinojosa², L. Edo Caballero², A. Carpi Medina², A. Villaubi Serra², N. Palo Mauriz², E. Membrilla Fernandez², J. Alvarez Garcia²

Abstract Number: PO0002

Bleeding disorder in a critically ill patient

R. Pombal¹, L. Vieira², S. Lopes², R. Neto², J. Ribeiro², H. Gomes², M. Figueiredo³

Abstract Number: PB0483

Can Thrombin Generation Assay Predict Bleeding Risk in Patients with Severe Liver Failure?

A. Navaei¹, K. Bruzdoski², V. Kostousov¹, L. Hensch³, S. Hui¹, J. Teruya¹